New Delhi-based Medicamen Biotech is foraying into domestic business with its subsidiary Medicamen Life Sciences Pvt Ltd. While issuing the press release, Medicamen group chairman Mr.

According to Rahul Bishnoi, Medicamen group Chairman, “The vision of the company is to become a most admired pharmaceutical organization by offering research & data backed, affordable & quality medicines for Indian population and to start with, the company has entered cardio-vascular & diabetes (CVD) business, which contributes annual revenue of more than Rs 50000 crore to the Indian pharma market with a CAGR of 11%”.

"Kamal Pahwa, a pharma veteran with 32 years of experience in CVD business and Pramod Sharma of Neelkanth Drugs, a leading distribution network in India, have joined hands with Medicamen to launch this very ambitious venture", said Bishnoi.

Medicamen Biotech was established in 1996, and till now has been focusing on international business. It has recently commenced its state of the art oncology plant at Haridwar which is meant for regulated market like US and Europe. Medicamen earlier this year had launched its high-quality oncology products in the domestic market.